Log In to Register
When and Where
  • 5/26/2020 11:00 AM EDT
  • 5/26/2020 12:00 PM EDT
  • FCBA Office
  • Washington
  • DC

Originally scheduled as part of the live Global Series Event in Washington, D.C., this panel of thought leaders has agreed to bring their thoughts (and faces) to you LIVE via this Zoom meeting to discuss the types of incentives (and disincentives) that exist in the Global IP community and their impact on innovation. Innovation lies at the heart of tremendous value, both in a monetary and societal sense. The question is how do worldwide systems and corporate research and development efforts support and encourage innovation while at the same time addressing varying administrative, regulatory, and political needs. The panelists will discuss their viewpoints including:

• Medtech perspective on innovation and incentives with an overview from startup ecosystems to aggregators to investors, focusing on practical experience and experience with what works and what does not.
• Recent PTO initiatives related to promoting new COVID-19 treatments on the market more quickly, discussion of the COVID-19 Prioritized Examination Trial Program and the Patents 4 Partnerships IP marketplace platform.
• Tech perspective and global incentive systems from different vantage points, discussion of compulsory reward system in China and comparison to other systems in terms of impact on innovation.
• Inventor incentives globally, importance of certainty in marketplace for IP, discussion of laws, e.g., antitrust laws, that incentivize or discourage innovation or add to the uncertainty investors and patentees face.

The panelists will encourage interaction with audience members throughout.


Moderator:
Laura Masurovsky, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Panelists:
Eb Bright, Co-founder, Alliance of U.S. Startups & Inventors for Jobs (USIJ)
Bill Harmon, Director, IP and Trademarks, Uber Technologies, Inc.
Philip Hirschhorn, Partner, Panitch Schwarze Belisario & Nadel LLP
Liane Peterson, Partner, Foley & Lardner LLP